| Titre : | Use of nonprescription weight loss products : Results from a multistate survey. (2001) |
| Auteurs : | Heidi-Michels BLANCK ; Laura-Kettel KHAN ; Mary-K SERDULA ; Division of Nutrition and Physical Activity. National Center for Chronic Disease Prevention and Health Promotion. Centers for Disease Control and Prevention. Atlanta. GA. USA |
| Type de document : | Article |
| Dans : | JAMA - Journal of the american medical association (vol. 286, n° 8, 2001) |
| Pagination : | 930-935 |
| Langues: | Anglais |
| Mots-clés : | Obésité ; Amaigrissement ; Thérapeutique médicamenteuse ; Chimiothérapie ; Prévalence ; Epidémiologie ; Etats Unis ; Amérique ; Adulte ; Homme ; Maladie nutrition ; Thérapeutique ; Amérique du Nord |
| Résumé : | [BDSP. Notice produite par INIST-CNRS kp90R0xm. Diffusion soumise à autorisation]. Context Lifestyle changes to lose weight can be difficult ; hence, both prescription and nonprescription diet products are appealing. Usage patterns of the nonprescription products phenylpropanolamine (PPA) and ephedra are of particular interest because of recent safety concerns. Objective To estimate the prevalence of overall and specific nonprescription weight loss product use by demographic characteristics, prescription diet pill use, diabetic status, and lifestyle choices. Design and Setting The Behavioral Risk Factor Surveillance System, a random-digit telephone survey conducted in 1998 in 5 states : Florida, lowa, Michigan, West Virginia, and Wisconsin. Participants Population-based sample of 14679 noninstitutionalized adults 18 years or older. Main Outcome Measures Prevalence of nonprescription weight loss product use in 1996-1998. Results Seven percent reported overall nonprescription weight loss product use, 2% reported PPA use, and 1% reported ephedra product use. Overall use was especially common among young obese women (28.4%). Moreover, 7.9% of normal-weight women reported use. There was no difference in nonprescription weight loss product use by daily consumption of fruits and vegetables ; however, more users than nonusers reported being physically active (for those who exercised>=30 minutes 5 times per week, odds ratio, 1.5 ; 95% confidence interval, 1.2-2.0). Among prescription weight loss product users, 33.8% also took nonprescription product. Conclusions With increasing rates of obesity, nonprescription product use is likely to increase. Clinicians should know about their patients'use of both prescription and nonprescription weight loss products. |
Service Documentation EHESP
Me connecter
PORTAIL DOCUMENTAIRE
École des hautes études en santé publique
Catalogue
Multi-bases
Accueil
Sélection de la langue
Adresse
Service Documentation EHESPBibliothèque Rennes Avenue du Professeur Léon Bernard – CS 74312 – 35043 Rennes Cedex Bibliothèque MSSH Paris 20 avenue George Sand - 93210 La Plaine Saint-Denis
France
Bibliothèque Rennes : 02 99 02 29 50 Bibliothèque MSSH Paris : 02 99 02 24 50
contact